United States · FDA National Drug Code directory

losartan potassium and hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
29300-190_ad6e4664-08b6-4480-a1fb-6663c8024fef
Product NDC
29300-190
Form
TABLET, FILM COATED
Composition / generic term
losartan potassium and hydrochlorothiazide
Labeler
Unichem Pharmaceuticals (USA), Inc.
Marketing category
ANDA
Marketing start / end (source format)
20170721
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 12.5 mg/1
  • LOSARTAN POTASSIUM — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-190-01) · 29300-190-01
  • 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-190-10) · 29300-190-10
  • 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-190-13) · 29300-190-13
  • 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-190-19) · 29300-190-19

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →